Topic Hub
83 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 83 of 83 clinical reviews.
A physician-reviewed breakdown of AOD 9604 (HGH Fragment 176-191), its fat-loss mechanism, clinical trial results, safety data, and how it compares to melanotan peptides and myostatin inhibitors.
Read clinical reviewA direct clinical comparison of AOD9604 and HGH Fragment 176-191, plus BPC-157 vs TB-500, IGF-1 vs IGF-1 LR3, Semax vs Selank, and GHRP-2 vs Ipamorelin. Reviewed by HealthRX physicians.
Read clinical reviewA deep-dive into ARA 290 (cibinetide), a non-hematopoietic erythropoietin peptide fragment studied for neuropathic pain, inflammation, and metabolic repair. Includes trial data, dosing context, and comparisons with epitalon, MOTS-c, SS-31, and humanin.
Read clinical reviewA physician-reviewed guide covering US peptide legality, FDA status, compounding rules, drug testing, injection technique, oral bioavailability, and cycling protocols with primary-source citations.
Read clinical reviewA clinician-reviewed guide to argireline (acetyl hexapeptide-3), SNAP-8, Matrixyl, copper peptides, and topical dermorphin. Includes dosing, mechanism, clinical trial data, and how to choose the right peptide for your skin goals.
Read clinical reviewA physician-reviewed guide to BPC-157 for gut healing, covering mechanisms, dosing, comparisons with thymosin alpha-1, thymulin, larazotide, and KPV, plus real trial data and clinical context.
Read clinical reviewA clinician-reviewed breakdown of BPC-157 fragments, their mechanism of action, comparison with TB-500 fragments, GHRP-2 vs GHRP-6, N-acetyl epitalon, and how regen peptide stacks are built for tissue repair and recovery.
Read clinical reviewA clinical comparison of BPC-157 and TB-500 covering mechanisms, dosing, stacking, and how each compares to GHRP-2, Ipamorelin, Semax, Selank, and Epitalon for recovery and longevity goals.
Read clinical reviewMost peptides are destroyed in the gut before reaching the bloodstream. Learn which peptides can be taken orally, which require injection, and what the science says about absorption, legality, and safety.
Read clinical reviewA physician-reviewed guide on whether therapeutic peptides appear on standard urine, blood, or sports drug tests, plus their legal status, injection considerations, oral bioavailability, and cycling protocols.
Read clinical reviewA physician-reviewed guide to the five most-studied neurotropic peptides: cerebrolysin, semax, selank, dihexa, and pinealon. Covers mechanisms, clinical evidence, dosing, safety, and how to tell which patients may benefit.
Read clinical reviewA clinician-reviewed guide to cosmetic peptides beyond GHK-Cu, covering argireline, matrixyl, SNAP-8, and topical dermorphin analogues. Includes real trial data, dosing, and how each peptide works mechanistically.
Read clinical reviewA head-to-head clinical comparison of eight cosmetic and specialty peptides, including BPC-157 vs TB-500, IGF-1 vs IGF-1 LR3, Semax vs Selank, and GHRP-2 vs Ipamorelin, with dosing, mechanisms, safety profiles, and guidance on which to choose.
Read clinical reviewA clinician-reviewed deep-dive into davunetide (NAP/AL-108/AL-208), covering its mechanism of action, clinical trial data from PSP and AD studies, dosing, safety, and how it compares with semax, selank, cerebrolysin, and dihexa for neuroprotection.
Read clinical reviewA clinical deep-dive into dermorphin topical applications, argireline, Matrixyl, SNAP-8, and copper peptides beyond GHK-Cu. Evidence-based guidance on doses, mechanisms, and what to realistically expect.
Read clinical reviewA clinical deep-dive into dihexa, covering mechanism of action, research data, comparisons with semax, selank, cerebrolysin, and pinealon, dosing ranges used in trials, and safety considerations reviewed by HealthRX physicians.
Read clinical reviewA physician-reviewed breakdown of four specialty peptides, DSIP, PT-141 (bremelanotide), kisspeptin-10, and oxytocin, covering mechanisms, dosing, evidence, and clinical use cases.
Read clinical reviewA clinician-reviewed comparison of Epitalon and TB-500 for longevity, covering mechanisms, dosing, evidence, and how they stack against BPC-157, IGF-1 LR3, Semax, Selank, GHRP-2, and Ipamorelin.
Read clinical reviewA physician-reviewed guide to five longevity peptides, covering mechanisms, clinical and preclinical evidence, dosing data, regulatory status, and how to evaluate them safely.
Read clinical reviewA clinician-reviewed guide to FDA 503A compounded peptides covering legal status, purity standards, sterility testing, storage stability, and how they differ from unregulated research peptides.
Read clinical reviewA clinician-reviewed guide to FOXO4-DRI, covering its mechanism, the 2017 mouse data, human evidence gaps, safety unknowns, and how it compares with epitalon, MOTS-c, SS-31, and humanin.
Read clinical reviewA clinical comparison of GHRP-2 and GHRP-6 growth hormone-releasing peptides covering potency, appetite effects, cortisol response, and stacking with BPC-157, TB-500 fragments, and regenerative peptide protocols.
Read clinical reviewA clinical comparison of GHRP-2 and ipamorelin covering mechanism, dosing, side-effect profiles, and how each fits into a broader peptide stack including BPC-157, TB-500, IGF-1 LR3, Semax, Selank, and Epitalon.
Read clinical reviewA physician-reviewed guide to hexarelin, covering its mechanism, clinical evidence, dosing protocols, safety data, and comparisons with epitalon, MOTS-c, SS-31, and humanin.
Read clinical reviewA clinically grounded review of HGH Fragment 176-191 (AOD 9604), covering mechanism, fat-loss data, dosing, side effects, melanotan comparisons, and myostatin inhibitor context, reviewed by the HealthRX medical team.
Read clinical reviewA clinician-reviewed guide to humanin, covering its mechanism, reported benefits, dosing data from published trials, comparisons with epitalon, MOTS-c, SS-31, and FOXO4-DRI, and what the current FDA regulatory landscape means for patients.
Read clinical reviewA clinician-reviewed guide to IGF-1 DES: how it differs from IGF-1 LR3, what the receptor-binding data show, realistic dosing windows, and when a prescriber might consider it.
Read clinical reviewA comprehensive clinical guide to IGF-1 LR3, covering its molecular mechanism, differences from native IGF-1 and IGF-1 DES, IGFBP modulation, MGF comparison, dosing protocols, and the current evidence base with primary-source citations.
Read clinical reviewA clinical comparison of IGF-1 and IGF-1 LR3: half-life, receptor binding, anabolic potency, dosing protocols, side-effect profiles, and how each fits into a broader peptide stack with BPC-157, TB-500, GHRP-2, Ipamorelin, Semax, Selank, and Epitalon.
Read clinical reviewA clinician-reviewed guide to IGF-1, IGF-1 LR3, IGF-1 DES, mechano growth factor, and IGFBP modulation. Covers physiology, dosing, safety, and what current research actually supports.
Read clinical reviewA clinician-reviewed guide to IGF-1, IGF-1 LR3, IGF-1 DES, MGF, and the binding-protein system that gates their activity. Includes dosing context, mechanism data, and safety considerations.
Read clinical reviewA clinician-reviewed guide to building an immune peptide stack. Covers thymosin alpha-1, thymulin, KPV, and larazotide with doses, trial data, safety, and how each peptide fits a specific immune target.
Read clinical reviewA clinician-reviewed guide to kisspeptin 10, covering its mechanism, dosing, evidence base, and comparison with PT-141 (bremelanotide), therapeutic oxytocin, and DSIP. Includes real trial data and prescriber guidance.
Read clinical reviewA clinician-reviewed guide to KPV and systemic immune peptides, including thymosin alpha-1, thymulin, and larazotide. Covers mechanisms, dosing evidence, regulatory status, and stacking considerations.
Read clinical reviewA physician-reviewed deep dive into larazotide, thymosin alpha-1, KPV, and thymulin: how each peptide works, what the human trial data actually show, dosing ranges used in practice, and how clinicians are beginning to stack them.
Read clinical reviewA physician-reviewed guide to leptin-derived peptides including AOD 9604, HGH fragment 176-191, melanotan 1, and melanotan 2. Covers mechanisms, clinical trial data, dosing research, and real safety risks.
Read clinical reviewA clinician-reviewed guide to the LF-15 Camel peptide stack, covering thymosin alpha-1, thymulin, larazotide, and KPV systemic. Includes mechanisms, dosing protocols, clinical trial data, and regulatory status.
Read clinical reviewA physician-reviewed guide to longevity peptide stacks, covering Epitalon, MOTS-C, SS-31, and Humanin: mechanisms, clinical evidence, dosing protocols, and safety considerations.
Read clinical reviewA clinician-reviewed guide to topical peptides for skin aging, covering Matrixyl (palmitoyl pentapeptide-4), Argireline (acetyl hexapeptide-3), SNAP-8, GHK-Cu, and emerging compounds. Includes trial data, doses, and practical protocol guidance.
Read clinical reviewA clinical breakdown of Melanotan 1 (afamelanotide), its FDA-designated status, melanocortin receptor mechanism, real trial data, and how it compares to AOD 9604, HGH Frag 176-191, Melanotan 2, and experimental myostatin inhibitors.
Read clinical reviewA clinical review of melanotan 2 risks, covering cardiovascular effects, melanoma risk, nausea, and comparisons with AOD 9604, HGH Frag 176-191, melanotan 1, and myostatin inhibitors. Reviewed by the HealthRX medical team.
Read clinical reviewA clinician-reviewed guide to melatonin and cosmetic peptides for skin aging, covering argireline, matrixyl, SNAP-8, GHK-Cu, and emerging copper peptide variants with real trial data and dosing context.
Read clinical reviewA clinician-reviewed guide to MGF mechano growth factor, its relationship to IGF-1 splice variants, IGF-1 LR3, IGF-1 Des, and IGFBP modulation, with full citations to primary research.
Read clinical reviewA physician-reviewed guide to mitochondrial and longevity peptides including MOTS-c, Epitalon, SS-31, Humanin, and FOXO4-DRI. Covers mechanisms, clinical and preclinical evidence, dosing, safety, and regulatory status.
Read clinical reviewA clinical review of myostatin inhibitors, AOD 9604, HGH fragment 176-191, melanotan 1, and melanotan 2, including trial data, FDA status, and safety risks.
Read clinical reviewA physician-reviewed guide to N-acetyl epitalon, covering its telomere biology, comparison with standard epitalon, regenerative peptide stacks including BPC-157 and TB-500 fragments, GHRP-2 vs GHRP-6 dosing, and current evidence gaps.
Read clinical reviewA clinician-reviewed guide to N-Acetyl Semax covering mechanism of action, BDNF effects, comparisons with Semax, Selank, Dihexa, and Cerebrolysin, dosing ranges, and what current research does and does not support.
Read clinical reviewA clinician-reviewed overview of the leading nootropic peptides, including Semax, Selank, Cerebrolysin, and Dihexa. Covers mechanisms, doses, trial data, safety profiles, and prescribing considerations.
Read clinical reviewA physician-reviewed guide to therapeutic oxytocin covering intranasal dosing, libido, anxiety, autism, PT-141 comparison, kisspeptin-10, DSIP, and the latest trial data.
Read clinical reviewA clinician-reviewed guide to P21 peptide covering its mechanism, comparison with Semax, Selank, Cerebrolysin, and Dihexa, the current evidence base, dosing concepts, and safety considerations.
Read clinical reviewA clinician-reviewed guide to PE-22-28, covering its mechanism as a TREK-1 potassium channel blocker, evidence from preclinical studies, comparisons with Semax, Selank, Cerebrolysin, and Dihexa, dosing protocols, and safety data.
Read clinical reviewA clinician-reviewed deep dive into PEG-MGF, covering its mechanism, dosing protocols, comparison with TB-500 and BPC-157 fragments, the regen peptide stack, and N-acetyl epitalon co-administration.
Read clinical reviewEverything patients need to know about receiving peptides by air shipment: legality, storage on arrival, injection pain, drug testing, and oral bioavailability, with primary-source citations throughout.
Read clinical reviewA clinical guide to peptide cycling protocols, legal status in the US, injection technique, oral bioavailability, and drug-test implications. Reviewed by the HealthRX medical team.
Read clinical reviewA clinician-reviewed guide to peptides for hair loss, covering GHK-Cu, PTD-DBM, AnaGain, and topical peptide stacks, with dosing, evidence, and what to expect.
Read clinical reviewA clinician-reviewed guide covering peptide half-life science, how long common therapeutic peptides stay active, injection site pain, oral absorption limits, drug-test detection, and US legal status. Includes real doses, named trials, and sourced statistics.
Read clinical reviewA clinician-reviewed guide to peptide injection frequency covering dosing schedules for BPC-157, CJC-1295, ipamorelin, semaglutide, and more. Includes legal status, drug-test considerations, oral bioavailability, and pain management.
Read clinical reviewPeptide injection pain explained by the HealthRX medical team. Learn why subcutaneous peptide shots hurt, how to reduce discomfort, injection technique tips, legality, drug testing, oral bioavailability, and cycling protocols.
Read clinical reviewLearn exactly how to inject peptides safely at home, including subcutaneous and intramuscular technique, site rotation, pain management, legal status in the US, and whether peptides appear on drug tests.
Read clinical reviewA clinician-reviewed guide to peptide drug interactions, FDA 503A compounding rules, purity testing methods, and stability data for medical-grade peptide therapy.
Read clinical reviewShowing the first 60 matches. Use search or filters to narrow the library.